Numerous healthcare organizations have joined forces to launch a new ad campaign focused on helping black women learn more about monitoring and managing their blood pressure.

The guidelines were specifically designed so that they could apply to patients from any country or socioeconomic group.

Antihypertensive medications don’t increase a person’s risk of testing positive for COVID-19, according to new research published in the New England Journal of Medicine.

There’s a reason to feel quite optimistic about these numbers—the rise comes from an updated definition of hypertension, one first suggested by the American College of Cardiology and American Heart Association.

Researchers have launched a new multi-center clinical trial aimed at learning more about how various blood pressure medications impact the health of patients with COVID-19.   

“If the devices haven’t been properly validated for accuracy, treatment decisions could be based on incorrect information.”

What, exactly, do patients need to know about the relationship between hypertension and COVID-19?

Americans are dying from cardiovascular disease (CVD) caused or exacerbated by hypertension at alarmingly higher rates than in years past.

When evaluating a pediatric patient for hypertension, healthcare providers often monitor the child’s blood pressure for a 24-hour period. However, according to new findings published in the Clinical Journal of the American Society of Nephrology, such “blood pressure load” assessments may not provide significant value.  

The British Heart Foundation (BHF) has published a statement warning patients with certain medical conditions, including cardiovascular diseases, to be “extra vigilant” as the new coronavirus continues to spread.

Patients with cardiovascular disease should continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) as prescribed if they are diagnosed with the new coronavirus (COVID-19), according to a joint statement from three medical societies. 

Hypertensive patients may be at a greater risk of dying from COVID-19, the viral disease stemming from the world’s largest coronavirus outbreak to date, according to Bloomberg News.